Elyxium Wealth’s Roivant Sciences ROIV Stock Holding History

Elyxium Wealth’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31.6K	Buy	+865	New	+$31.4K	﹤0.01%	741

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Cache Advisors San Francisco, California $1.63B AUM 33.42% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Elyxium Wealth's ROIV Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Roivant Sciences (ROIV) in Q3 2026: 865 shares worth $31.6K. The stake represents ﹤0.01% of the portfolio and ranks #741 among its holdings.

140 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

Elyxium Wealth held 865 shares of Roivant Sciences worth $31.6K as of Q3 2026.
Roivant Sciences was a new Elyxium Wealth position in Q3 2026.
Roivant Sciences made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #741 holding.
140 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.